Triple Inhaled Therapy in COPD: Current Guidelines, Benefits/Risks, and ETHOS Trial Discussion

Password

Forgot your password?

Select specialty

First name

Last name

Choose Password

Playback speed

10 seconds

By National Jewish Health FEATURING James P. Woodrow

4,982 views

August 12, 2021

James Woodrow, MD, of National Jewish Health, discusses the article “Triple Inhaled Therapy at Two ...
read more ↘ Glucocorticoid Doses in Moderate to Very Severe COPD” during the 30-minute inaugural webinar of the COPD Journal Club on August 3, 2021.

View the Article Summary:

Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate to Very Severe COPD (ETHOS Trial) N England J Med 2020; 383:35-48.

https://www.nationaljewish.org/education/pro-ed/live-events/national-jewish-health-journal-clubs/pdfs/copd-article-summary-triple-therapy_vol1_issue1.aspx
↖ read less

Comments 1